Analyst Ratings for Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (CBD)

Updated: 2017-07-27

Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (NYSE:CBD) was awarded an average rating of Overweight from investment analysts following the stock. A consensus rating of Overweight was previously issued for CBD last month.

A buy rating was issued by 8 analysts, 0 gave an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for CBD by the analysts covering the stock. The most optimistic price target was 27.88, implying a possible profit of 22.77 percent. The most pessimistic analyst gave a price target of 21.17, implying a possible loss of -6.78 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 250 percent. That number becomes 0 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed downwards by -0.94 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.14 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 1 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Over the same time period, 1 analysts revised their FY earnings estimates upwards, while 2 analysts made negative revisions to their fiscal year's estimates.

CBD has a 52-week high of 24.75 and a 52-week low of 14.08. Today's price is 61.29 percent above the 52-week low, and 8.24 percent below the high. CBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The CBD value stock report compares CBD to some of its peers using value stock charts. The stock has a market capitalization of $5.18 billion. CBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.